| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/05/2001 | CA2386085A1 Piperidine derivatives |
| 04/05/2001 | CA2386079A1 Compounds for the treatment of ischemia |
| 04/05/2001 | CA2386029A1 P-glycoproteins from macaca fascicularis and uses thereof |
| 04/05/2001 | CA2386002A1 Trail: an inhibitor of autoimmune inflammation and cell cycle progression |
| 04/05/2001 | CA2386000A1 Treatment of diabetic nephropathy and microalbuminuria |
| 04/05/2001 | CA2385990A1 Compositions having improved stability |
| 04/05/2001 | CA2385989A1 Compositions of tocol-soluble therapeutics |
| 04/05/2001 | CA2385971A1 Vasopressin agonist formulation and process |
| 04/05/2001 | CA2385967A1 Use of cholesterol derivatives for modulating sphingolipid-cholesterol microdomains |
| 04/05/2001 | CA2385883A1 Human carboxypeptidases and polynucleotides encoding the same |
| 04/05/2001 | CA2385749A1 Melt granulated composition and modified release dosage form prepared from said composition |
| 04/05/2001 | CA2385737A1 Piperazine derivatives as 5-ht1b antagonists |
| 04/05/2001 | CA2385493A1 Sebum production inhibitors |
| 04/05/2001 | CA2385490A1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis |
| 04/05/2001 | CA2385349A1 Method for the treatment or prevention of viral infection using nucleoside analogues |
| 04/05/2001 | CA2385327A1 Combined therapies for atherosclerosis treatment |
| 04/05/2001 | CA2385295A1 Novel fucosylated oligosaccharides and process for their preparation |
| 04/05/2001 | CA2385001A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/05/2001 | CA2384997A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/05/2001 | CA2384981A1 P-glycoproteins and uses thereof |
| 04/05/2001 | CA2384840A1 Use of pramipexole as a treatment for cocaine craving |
| 04/05/2001 | CA2384731A1 Compositions for reducing sympathomimetic-induced side effects by serenoa repens extract |
| 04/05/2001 | CA2384692A1 Novel tropane analogs |
| 04/05/2001 | CA2384584A1 38 human secreted proteins |
| 04/05/2001 | CA2384509A1 Scar treatment composition |
| 04/05/2001 | CA2384265A1 Benzodiazepin derivatives, the production and use thereof |
| 04/05/2001 | CA2382892A1 Substituted benzimidazol derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 04/05/2001 | CA2382808A1 22196, a novel human aminopeptidase |
| 04/05/2001 | CA2379595A1 Oral controlled release formulations |
| 04/05/2001 | CA2352957A1 Isonipecotamides for the treatment of integrin-mediated disorders |
| 04/05/2001 | CA2352194A1 Azepinoindole derivatives, the production and use thereof |
| 04/04/2001 | EP1088900A1 Polymorphisms in the human CYP3A4, CYP3A7 and hPXR genes and their use in diagnostic and therapeutic applications |
| 04/04/2001 | EP1088832A1 Highly resistant granular starch |
| 04/04/2001 | EP1088828A2 Synthesis of carbamate ketolide antibiotics |
| 04/04/2001 | EP1088826A1 Process for the preparation of potassium clavulanate |
| 04/04/2001 | EP1088824A2 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 04/04/2001 | EP1088823A1 Fused pyrrolocarbazoles |
| 04/04/2001 | EP1088822A1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 04/04/2001 | EP1088821A1 Pharmaceutically active sulfonamide derivatives |
| 04/04/2001 | EP1088819A2 6-azauracil derivatives as thyroid receptor ligands |
| 04/04/2001 | EP1088816A2 Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension |
| 04/04/2001 | EP1088815A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/04/2001 | EP1088554A1 Controlled release drug association containing 5-isosorbide mononitrate and acetylsalicylic acid |
| 04/04/2001 | EP1088553A1 Immunosuppressant containing glucopyranose derivative as active ingredient |
| 04/04/2001 | EP1088552A1 Compositions containing pinolenic acid and its use a health component |
| 04/04/2001 | EP1088551A1 Medicinal compositions for treating evacuatory insufficiency |
| 04/04/2001 | EP1088550A1 alpha-sulfonylamino hydroxamic acid inhibitors of matrix metallo-proteinases for the treatment of peripheral or central nervous system disorders |
| 04/04/2001 | EP1088549A1 Modafinil having defined particle size |
| 04/04/2001 | EP1088548A2 Use of alverine for reducing wrinkles |
| 04/04/2001 | EP1088547A2 Combinations of active substances respectively adducts from biotin and/or biotin derivatives with cyclodextrins and use of such combinations of active substances in cosmetic preparations |
| 04/04/2001 | EP1088535A1 Silk clothes for protecting affected parts |
| 04/04/2001 | EP1088486A2 Stable powder compositions comprising vitamins and/or carotenoids and their preparation |
| 04/04/2001 | EP1088481A2 Fungicides for the control of take-all disease of plants |
| 04/04/2001 | EP1088333A1 Compositions and methods for inhibiting bone resorption |
| 04/04/2001 | EP1088104A2 Methods for treating a neurological disease by determining bche genotype |
| 04/04/2001 | EP1088098A2 Fitness assay and associated methods |
| 04/04/2001 | EP1088065A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| 04/04/2001 | EP1087994A1 INTERACTION OF p27(KIP1) WITH FKBP-12 |
| 04/04/2001 | EP1087988A1 Meiosis regulating compounds |
| 04/04/2001 | EP1087987A1 A compound, wf002, production thereof and use thereof |
| 04/04/2001 | EP1087986A1 7.alpha.-methyl 19-nortestosterone undecanoate with androgenic activity |
| 04/04/2001 | EP1087981A2 Prenyl transferase inhibitors |
| 04/04/2001 | EP1087980A1 Derivatives of 3-(2-oxo- 1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems |
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087976A1 Polymorphic clopidogrel hydrogenesulphate form |
| 04/04/2001 | EP1087973A1 Imidazotriazolopyrimidines used as a drug having an adenosine antagonist activity |
| 04/04/2001 | EP1087972A1 Triazolo-pyrimidines as ligands for gaba receptors |
| 04/04/2001 | EP1087971A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087970A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087968A1 Triazolo-pyridine derivatives as ligands for gaba receptors |
| 04/04/2001 | EP1087966A1 Chemical synthesis of morpholine derivatives |
| 04/04/2001 | EP1087964A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
| 04/04/2001 | EP1087963A1 Inhibitors of glycogen synthase kinase 3 |
| 04/04/2001 | EP1087961A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 04/04/2001 | EP1087960A1 Macrocyclic analogs and methods of their use and preparation |
| 04/04/2001 | EP1087959A1 Novel benzopyran or thiobenzopyran derivatives |
| 04/04/2001 | EP1087954A1 Cycloalkyl-substituted aryl-piperazines, piperidines and tetrahydropyridines as serotonergic agents |
| 04/04/2001 | EP1087953A1 Nitrate salts of antihypertensive medicines |
| 04/04/2001 | EP1087951A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 04/04/2001 | EP1087950A1 New 2-aminocarbonyl-5(2h)-isoxazolones as ligands of a dfp-binding site for treatment of cns-diseases |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087943A1 Therapeutic biaryl derivatives |
| 04/04/2001 | EP1087941A2 Thiolesters and uses thereof |
| 04/04/2001 | EP1087938A1 Inhibitors of neuraminidases |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP1087935A1 Anthracene derivatives as anti-cancer agents |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP1087926A2 Analytic substrates and antioxidative agents |
| 04/04/2001 | EP1087801A1 Topoisomerase inhibitors for prevention of restenosis |
| 04/04/2001 | EP1087791A1 Inhibition of xenoreactive antibodies |
| 04/04/2001 | EP1087790A2 Use of a compound having affinity for the benzodiazepine mitochondrial receptor in cancer therapy |
| 04/04/2001 | EP1087781A1 Dietary supplement for supporting cerebrovascular tone |
| 04/04/2001 | EP1087780A1 Extraction method, pharmaceutical composition and a cosmetic composition |
| 04/04/2001 | EP1087779A2 Compositions for increasing energy in vivo |
| 04/04/2001 | EP1087778A1 Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c |
| 04/04/2001 | EP1087777A2 Therapeutic dinucleotide and derivatives |
| 04/04/2001 | EP1087776A1 A process for the treatment of organophosphate poisoning |
| 04/04/2001 | EP1087775A1 Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
| 04/04/2001 | EP1087774A2 Compositions for treating cartilage disease comprising certain sulfur-containing heterocyclic compounds |
| 04/04/2001 | EP1087773A1 Vaginal active agent delivery procedures and formulations thereof |